Therapy of late chronic phase myelogenous leukemia (CML) with high-dose Gleevec (ST1571)
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Sep 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 25 Sep 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center record.